Defibrotide for Patients With Hepatic Veno-occlusive Disease: A Treatment IND Study
Status:
Completed
Trial end date:
2016-09-01
Target enrollment:
Participant gender:
Summary
Single arm, open-label study to provide Defibrotide to patients diagnosed with VOD.
Defibrotide is no longer available though the Emergency Use IND mechanism (also known as
compassionate use, or single patient named use). This protocol is the only mechanism by which
Defibrotide can be made available to patients in the U.S.